CMS Open Payments · Program Year 2024
Coltene Whaledent Inc.
Coltene Whaledent Inc. reported $105,099.44 across General Payments, Research, and Ownership to 222 physicians and teaching hospitals across 222 transactions.
- $105.1K Below-median payer
- All-tracks total
- 222 Above-median volume
- Transactions
- 222 Above-median reach
- Recipients
- −$12.3K
- General Payments vs PY2023
Coltene Whaledent Inc. reported $105,099.44 across all CMS Open Payments tracks (General + Research + Ownership) to 222 physicians and teaching hospitals in Program Year 2024 - ranking #1170 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $105,099.44, averaging $473.42 per recipient.
Coltene Whaledent Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
31/100
Total payments
F
11/100
Transaction volume
F
12/100
Physician reach
F
12/100
Payment type diversity
A
90/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer coltene-whaledent-inc Coltene Whaledent Inc.
$105.1K · #1170/1,925 · 0.0% industry · PY2024
- TOT $105.1K
- RANK #1170
- SHARE 0.0%
- TXN 222
- RCP 222
- CAT 7
- GEN $105.1K
- ΔGEN −$12.3K
- TOP1 20.6%
- PY 2024
Volume peers
Nearest volume peer: Pylant Medical ($104.7K)
Coltene Whaledent Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Coltene Whaledent Inc.'s CMS-reported General Payments decreased by $12.3K (−10.5%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: COLTENE WHALEDENT INC.PY2023: COLTENE WHALEDENT INC.PY2024: Coltene Whaledent Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $117,438.11
- PY2024
- $105,099.44
What the Data Shows for Coltene Whaledent Inc.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Coltene Whaledent Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
Of the 7 general-payment categories charted below, "Honoraria" is the largest at $75.8K across 19 transactions, 72.1% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Coltene Whaledent Inc. made 7 types of general payments. "Honoraria" is the largest category at $75.8K, 72.1% of General Payments.
Coltene Whaledent Inc. reports 7 general-payment categories - the top three are Honoraria (72.1%), Gift (20.6%), and Entertainment (3.5%). The remaining 4 categories make up 3.8% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Coltene Whaledent Inc. divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Honoraria | $75.8K | 19 | 72.1% |
| Gift | $21.6K | 3 | 20.6% |
| Entertainment | $3.7K | 186 | 3.5% |
| Consulting Fee | $2.5K | 6 | 2.4% |
| Travel and Lodging | $905.20 | 4 | 0.9% |
| Food and Beverage | $302.11 | 2 | 0.3% |
| Education | $260.52 | 2 | 0.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $75,795.97 (72.1%) of $105,099.44 in this company's General Payments records across 157 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Coltene Whaledent Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Robert Sean Funk --
$21,605.50 across 3 reported transactions
- 2
Mario Fernando Romero
$16,160.97 across 5 reported transactions
- 3
Marcus D Johnson --
$14,230.53 across 5 reported transactions
- 4
Lundon Rusty Albrecht --
$13,138.86 across 9 reported transactions
- 5
Sam Alborz --
$10,660.11 across 6 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Coltene Whaledent Inc.'s spend rank (#1170 of 1,925, bottom 39% by spend) and concentration rank (#929 of 1,838, bottom 50% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Daiichi Sankyo Company LTD : $316.4K total payments, HHI 1293
- Collagen Matrix, Inc : $83.9K total payments, HHI 1290
- Nvision Biomedical Technologies, Inc. : $80.7K total payments, HHI 1290
- IMPLANET America, Inc. : $12.6K total payments, HHI 1277
- Aero US Inc : $19.3K total payments, HHI 1269
- Astellas Pharma Europe Ltd : $523.2K total payments, HHI 1263
- Coltene Whaledent Inc. (this company) : $105.1K total payments, HHI 1261
- Mylan Inc. : $367.4K total payments, HHI 1254
- RGH Enterprises LLC : $7.4K total payments, HHI 1248
- Summit Surgical Corp. : $5.2K total payments, HHI 1241
- Vector Surgical, LLC : $29.7K total payments, HHI 1240
- Mevion_Medical_Systems_Inc : $31.5K total payments, HHI 1237
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Coltene Whaledent Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Coltene Whaledent Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Coltene Whaledent Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Astute Medical, Inc.
OrthoPediatrics Canada ULC
Nxstage Medical, Inc.
Microgenics Corporation
HMU Consumables, LLC
Put this to use
Coltene Whaledent Inc. ranks #1170 of 1,925 by all-tracks total payments, led by "Honoraria".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Honoraria" spend across every manufacturer, not just Coltene Whaledent Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.